ERBB2 and neoplasm: A study with radiolabeled affibody ZHER2:342 demonstrated fast tumor uptake in xenograft models and provided a higher imaging-specific contrast in HER2-positive SKOV-3 xenografts than the HER2 scFv antibody fragment [35].